Patent Assignment
Reel/Frame 041817/0001
Assignment of Assignor's Interest
Recorded: 2017-02-26
Pages: 48
Assignor
BIOGEN MA INC.
Executed: 2017-01-31
Assignee
BIOVERATIV THERAPEUTICS INC.
225 SECOND AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Properties
(2)
Lyophilized Factor Ix Formulations
Patent:
10,772,942 →
Application:
15/128,951 →
Publication:
US 2017/0173122
PCT:
PCT/US2015/022141 ↗
Lyophilized Factor IX Formulations
Application:
61/969,801 →
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 29, 2014
From: THOME, BRIAN M.; PARKHURST-LANG, CHERIE; LEVEILLE, BRANDON W.
To: BIOGEN IDEC MA INC.
Reel/Frame 033409/0240 →
Assignment of Assignor's Interest
Jul 28, 2017
From: THOME, BRIAN M.; PARKHURST-LANG, CHERIE; LEVEILLE, BRANDON W.
To: BIOVERATIV THERAPEUTICS INC.
Reel/Frame 043125/0183 →